EU adopts SPC manufacturing waiver
EU committee approves SPC waiver
vepar5 / Shutterstock.com
The European Council has reached a political agreement on a proposal for the supplementary protection certificate (SPC) manufacturing waiver for patent-protected pharmaceuticals.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
European Council, European Commission, supplementary protection certificate, SPC manufacturing waiver, pharmaceuticals, biosimilars, JA Kemp